Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism

Abstract Background and Aims Chlordecone is a persistent organochlorinated insecticide, extensively used in the French West Indies and has been contaminating the population for more than thirty years. Its potentiation effect on hepatotoxic agents has been demonstrated in animal models. We investigat...

Full description

Bibliographic Details
Main Authors: Moana Gelu-Simeon, Marie-Josée Lafrance, Leah Michineau, Eric Saillard, Jean Pierre Thomé, Claude Emond, Michel Samson, Luc Multigner
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Environmental Health
Subjects:
Online Access:https://doi.org/10.1186/s12940-024-01054-6
_version_ 1827310027173527552
author Moana Gelu-Simeon
Marie-Josée Lafrance
Leah Michineau
Eric Saillard
Jean Pierre Thomé
Claude Emond
Michel Samson
Luc Multigner
author_facet Moana Gelu-Simeon
Marie-Josée Lafrance
Leah Michineau
Eric Saillard
Jean Pierre Thomé
Claude Emond
Michel Samson
Luc Multigner
author_sort Moana Gelu-Simeon
collection DOAJ
description Abstract Background and Aims Chlordecone is a persistent organochlorinated insecticide, extensively used in the French West Indies and has been contaminating the population for more than thirty years. Its potentiation effect on hepatotoxic agents has been demonstrated in animal models. We investigated the relationship between environmental exposure to chlordecone and the progression of liver fibrosis. Methods This study included 182 consecutive patients with chronic alcoholic hepatitis whose liver fibrosis was assessed using non-invasive methods. Measured plasma chlordecone concentrations at inclusion were used as surrogate of long-term exposure under steady-state conditions. As the pharmacokinetic processing of chlordecone is largely determined by the liver, we used a human physiologically based pharmacokinetic model to predict plausible changes in the steady-state blood chlordecone concentrations induced by liver fibrosis. Results With a median follow-up of 27.1 years after the onset of alcohol consumption, we found a significant decrease in the risk of advanced liver fibrosis with increasing plasma chlordecone concentration (adjusted hazard ratio = 0.56; 95% confidence interval: 0.34–0.95 for the highest vs. lowest tertile, p = 0.04). Changes induced by liver fibrosis influenced the pharmacokinetic processing of chlordecone, resulting in substantial modifications in its steady-state blood concentrations. Conclusion According to this human model of coexposure to alcohol, reverse causality is the most plausible explanation of this inverse association between plasma chlordecone concentrations and progression of liver fibrosis. This study underlines the importance of considering the pharmacokinetic of environmental contaminants in epidemiological studies when biomarkers of exposure are used to investigate their own impact on the liver. Trial registration ClinicalTrials.gov Identifier: NCT03373396.
first_indexed 2024-04-24T19:53:09Z
format Article
id doaj.art-b945bc8718214513b54b987e4d66ef1d
institution Directory Open Access Journal
issn 1476-069X
language English
last_indexed 2024-04-24T19:53:09Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Environmental Health
spelling doaj.art-b945bc8718214513b54b987e4d66ef1d2024-03-24T12:32:33ZengBMCEnvironmental Health1476-069X2024-03-012311910.1186/s12940-024-01054-6Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolismMoana Gelu-Simeon0Marie-Josée Lafrance1Leah Michineau2Eric Saillard3Jean Pierre Thomé4Claude Emond5Michel Samson6Luc Multigner7CHU de la Guadeloupe, Univ Antilles, Inserm, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085Service d’Hépato-Gastroentérologie, Centre Hospitalier Universitaire de GuadeloupeUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085Service d’Hépato-Gastroentérologie, Centre Hospitalier Universitaire de GuadeloupeUniversité de Liège, LEAE -CART, Freshwater and Oceanic Sciences Unit of Research (FOCUS)PKSH IncUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085Univ Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085Abstract Background and Aims Chlordecone is a persistent organochlorinated insecticide, extensively used in the French West Indies and has been contaminating the population for more than thirty years. Its potentiation effect on hepatotoxic agents has been demonstrated in animal models. We investigated the relationship between environmental exposure to chlordecone and the progression of liver fibrosis. Methods This study included 182 consecutive patients with chronic alcoholic hepatitis whose liver fibrosis was assessed using non-invasive methods. Measured plasma chlordecone concentrations at inclusion were used as surrogate of long-term exposure under steady-state conditions. As the pharmacokinetic processing of chlordecone is largely determined by the liver, we used a human physiologically based pharmacokinetic model to predict plausible changes in the steady-state blood chlordecone concentrations induced by liver fibrosis. Results With a median follow-up of 27.1 years after the onset of alcohol consumption, we found a significant decrease in the risk of advanced liver fibrosis with increasing plasma chlordecone concentration (adjusted hazard ratio = 0.56; 95% confidence interval: 0.34–0.95 for the highest vs. lowest tertile, p = 0.04). Changes induced by liver fibrosis influenced the pharmacokinetic processing of chlordecone, resulting in substantial modifications in its steady-state blood concentrations. Conclusion According to this human model of coexposure to alcohol, reverse causality is the most plausible explanation of this inverse association between plasma chlordecone concentrations and progression of liver fibrosis. This study underlines the importance of considering the pharmacokinetic of environmental contaminants in epidemiological studies when biomarkers of exposure are used to investigate their own impact on the liver. Trial registration ClinicalTrials.gov Identifier: NCT03373396.https://doi.org/10.1186/s12940-024-01054-6ChlordeconePersistent organic pollutantsLiver fibrosisReverse causality
spellingShingle Moana Gelu-Simeon
Marie-Josée Lafrance
Leah Michineau
Eric Saillard
Jean Pierre Thomé
Claude Emond
Michel Samson
Luc Multigner
Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
Environmental Health
Chlordecone
Persistent organic pollutants
Liver fibrosis
Reverse causality
title Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
title_full Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
title_fullStr Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
title_full_unstemmed Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
title_short Inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis: the role of liver metabolism
title_sort inverse association between plasma chlordecone concentrations and progression of alcoholic liver fibrosis the role of liver metabolism
topic Chlordecone
Persistent organic pollutants
Liver fibrosis
Reverse causality
url https://doi.org/10.1186/s12940-024-01054-6
work_keys_str_mv AT moanagelusimeon inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism
AT mariejoseelafrance inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism
AT leahmichineau inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism
AT ericsaillard inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism
AT jeanpierrethome inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism
AT claudeemond inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism
AT michelsamson inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism
AT lucmultigner inverseassociationbetweenplasmachlordeconeconcentrationsandprogressionofalcoholicliverfibrosistheroleoflivermetabolism